Nu-Med Plus Inc.

The Nu-Med Plus mission is to design, develop and market new patented technologies in the medical field along with building key intellectual assets. The company's strategy is to focus on high-growth markets with a clearly defined need recognized by the medical community. Nu-Med's initial focus is on medical products that deliver therapeutic doses of Inhaled Nitric Oxide (INO) to patients. INO is used in neonatal hypertension and many pulmonary crises, in addition to having the potential to treat problems from malaria to wound healing. The company's product candidates are designed to be less expensive and more user-friendly for clinicians and end-users, as well as disruptive to the market.